We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AQUIPTA (Allergan Australia Pty Ltd)
Product name
AQUIPTA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
211 (255 working days)
Active ingredients
atogepant
Registration type
NCE/NBE
Indication
AQUIPTA is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month